Puhlmann Markus bought CATX
January 24, 2024 · Form 4 insider transaction
Puhlmann Markus bought 280,000 shares of Perspective Therapeutics, Inc. at $0.50 per share, a transaction worth $139.9K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
This price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.4871 to $0.5000, inclusive. The reporting person undertakes to provide to Perspective Therapeutics, Inc., any security holder of Perspective Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.